jbog, the European Copaxone patents have no bearing whatsoever on Teva’s patent lawsuit against Mylan in the US, which was the subject of the PR you excerpted from.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”